These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 25071581)

  • 1. ABC transporters in CSCs membranes as a novel target for treating tumor relapse.
    Zinzi L; Contino M; Cantore M; Capparelli E; Leopoldo M; Colabufo NA
    Front Pharmacol; 2014; 5():163. PubMed ID: 25071581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salinomycin as a drug for targeting human cancer stem cells.
    Naujokat C; Steinhart R
    J Biomed Biotechnol; 2012; 2012():950658. PubMed ID: 23251084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tackling multidrug resistance mediated by efflux transporters in tumor-initiating cells.
    McIntosh K; Balch C; Tiwari AK
    Expert Opin Drug Metab Toxicol; 2016 Jun; 12(6):633-44. PubMed ID: 27116192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
    Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
    Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review.
    Dzobo K; Senthebane DA; Ganz C; Thomford NE; Wonkam A; Dandara C
    Cells; 2020 Aug; 9(8):. PubMed ID: 32823711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caveolin-1 mediates chemoresistance in breast cancer stem cells via β-catenin/ABCG2 signaling pathway.
    Wang Z; Wang N; Li W; Liu P; Chen Q; Situ H; Zhong S; Guo L; Lin Y; Shen J; Chen J
    Carcinogenesis; 2014 Oct; 35(10):2346-56. PubMed ID: 25085904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
    To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
    J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding of human ATP binding cassette superfamily and novel multidrug resistance modulators to overcome MDR.
    Mohammad IS; He W; Yin L
    Biomed Pharmacother; 2018 Apr; 100():335-348. PubMed ID: 29453043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
    Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
    Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular and molecular biology of cancer stem cells in melanoma: Possible therapeutic implications.
    Marzagalli M; Raimondi M; Fontana F; Montagnani Marelli M; Moretti RM; Limonta P
    Semin Cancer Biol; 2019 Dec; 59():221-235. PubMed ID: 31265892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer Stem Cells as a Potential Target to Overcome Multidrug Resistance.
    Cho Y; Kim YK
    Front Oncol; 2020; 10():764. PubMed ID: 32582535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advances in the targeting ATP-binding cassette transporters to overcome tumor multi-drug resistance].
    Wei N; Sun H; Liu GT
    Yao Xue Xue Bao; 2010 Oct; 45(10):1205-11. PubMed ID: 21348297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to drugs and cell death in cancer stem cells (CSCs).
    Safa AR
    J Transl Sci; 2020 Jun; 6(3):. PubMed ID: 35330670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells.
    Samuel SM; Varghese E; Koklesová L; Líšková A; Kubatka P; Büsselberg D
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32883003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways.
    Takebe N; Harris PJ; Warren RQ; Ivy SP
    Nat Rev Clin Oncol; 2011 Feb; 8(2):97-106. PubMed ID: 21151206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N,N-bis(cyclohexanol)amine aryl esters: the discovery of a new class of highly potent inhibitors of transporter-dependent multidrug resistance (MDR).
    Teodori E; Dei S; Martelli C; Scapecchi S
    Curr Top Med Chem; 2010; 10(17):1715-31. PubMed ID: 20645921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What "The Cancer Genome Atlas" database tells us about the role of ATP-binding cassette (ABC) proteins in chemoresistance to anticancer drugs.
    Briz O; Perez-Silva L; Al-Abdulla R; Abete L; Reviejo M; Romero MR; Marin JJG
    Expert Opin Drug Metab Toxicol; 2019 Jul; 15(7):577-593. PubMed ID: 31185182
    [No Abstract]   [Full Text] [Related]  

  • 20. Cancer stem cell theory: therapeutic implications for nanomedicine.
    Wang K; Wu X; Wang J; Huang J
    Int J Nanomedicine; 2013; 8():899-908. PubMed ID: 23467584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.